Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHCR
2676
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $5.24M | ﹤0.01% |
6,828,444
+72,845
| +1% | +$73K |
|
2677
Utah Medical Products
UTMD
$230M
| $5.24M | ﹤0.01% |
73,679
+1,659
| +2% | +$124K |
|
2678
Tilray
TLRY
$640M
| $5.24M | ﹤0.01% |
176,087
+36,839
| +26% | +$710K |
|
2679
Red River Bancshares
RRBI
$674M
| $5.21M | ﹤0.01% |
104,613
+2,677
| +3% | +$137K |
|
2680
Perspective Therapeutics
CATX
$372M
| $5.21M | ﹤0.01% |
437,568
+185,903
| +74% | +$1.59M |
|
2681
American Superconductor
AMSC
$1.56B
| $5.2M | ﹤0.01% |
384,741
+89,780
| +30% | +$1.11M |
|
2682
AerSale
ASLE
$269M
| $5.19M | ﹤0.01% |
722,671
+97,874
| +16% | +$903K |
|
2683
Amplify Energy
AMPY
$182M
| $5.19M | ﹤0.01% |
784,584
+15,345
| +2% | +$93.3K |
|
2684
Monte Rosa Therapeutics
GLUE
$1.36B
| $5.19M | ﹤0.01% |
735,533
+47,862
| +7% | +$284K |
|
|
CIO
2685
DELISTED
City Office REIT
CIO
| $5.18M | ﹤0.01% |
993,807
+26,776
| +3% | +$135K |
|
2686
Immersion
IMMR
$247M
| $5.15M | ﹤0.01% |
688,877
-8,311
| -1% | -$59.1K |
|
2687
Root
ROOT
$748M
| $5.14M | ﹤0.01% |
84,191
-2,087
| -2% | -$49.1K |
|
2688
Accuray
ARAY
$32.9M
| $5.14M | ﹤0.01% |
2,081,488
+84,412
| +4% | +$226K |
|
|
ONL
2689
Orion Office REIT
ONL
$161M
| $5.13M | ﹤0.01% |
1,462,106
+79,968
| +6% | +$359K |
|
2690
SGHC Ltd
SGHC
$6.51B
| $5.13M | ﹤0.01% |
1,487,487
+17,400
| +1% | +$55.7K |
|
2691
Civista Bancshares
CIVB
$595M
| $5.13M | ﹤0.01% |
333,293
+11,989
| +4% | +$192K |
|
2692
Vanda Pharmaceuticals
VNDA
$314M
| $5.12M | ﹤0.01% |
1,245,382
-121
| -0% | -$484 |
|
2693
Inspired Entertainment
INSE
$163M
| $5.12M | ﹤0.01% |
519,116
+18,140
| +4% | +$169K |
|
2694
Funko
FNKO
$331M
| $5.12M | ﹤0.01% |
820,093
+33,374
| +4% | +$234K |
|
|
DM
2695
DELISTED
Desktop Metal, Inc.
DM
| $5.11M | ﹤0.01% |
580,999
+18,544
| +3% | +$119K |
|
|
GRTS
2696
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $5.11M | ﹤0.01% |
1,987,792
+82,019
| +4% | +$200K |
|
2697
Southern First Bancshares
SFST
$607M
| $5.1M | ﹤0.01% |
160,635
+6,255
| +4% | +$215K |
|
2698
National CineMedia
NCMI
$252M
| $5.08M | ﹤0.01% |
985,392
+5,154
| +0.5% | +$21.9K |
|
2699
Mercer International
MERC
$32.3M
| $5.07M | ﹤0.01% |
509,770
+9,167
| +2% | +$82K |
|
2700
Neurogene
NGNE
$740M
| $5.06M | ﹤0.01% |
99,314
+83,595
| +532% | +$2.79M |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.